AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 292: G1019-G1028, 2007. First published January 4, 2007; doi:10.1152/ajpgi.00239.2006
0193-1857/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
292/4/G1019    most recent
00239.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brand, S.
Right arrow Articles by Auernhammer, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brand, S.
Right arrow Articles by Auernhammer, C. J.

LIVER AND BILIARY TRACT

IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro

Stephan Brand,1,* Julia Dambacher,1,* Florian Beigel,1 Kathrin Zitzmann,1 Malte H. J. Heeg,1 Thomas S. Weiss,3 Thomas Prüfer,1 Torsten Olszak,1 Christian J. Steib,1 Martin Storr,1 Burkhard Göke,1 Helmut Diepolder,1 Manfred Bilzer,1 Wolfgang E. Thasler,2 and Christoph J. Auernhammer1

1Department of Medicine II and 2Department of Surgery, University-Hospital Munich-Grosshadern and University of Munich, Munich; and 3Center for Liver Cell Research, University Hospital Regensburg, Regensburg, Germany

Submitted 1 June 2006 ; accepted in final form 20 December 2006

The IL-10-like cytokine IL-22 is produced by activated T cells. In this study, we analyzed the role of this cytokine system in hepatic cells. Expression studies were performed by RT-PCR and quantitative PCR. Signal transduction was analyzed by Western blot experiments and ELISA. Cell proliferation was measured by MTS and [3H]thymidine incorporation assays. Hepatocyte regeneration was studied in in vitro restitution assays. Binding of IL-22 to its receptor complex expressed on human hepatic cells and primary human hepatocytes resulted in the activation of MAPKs, Akt, and STAT proteins. IL-22 stimulated cell proliferation and migration, which were both significantly inhibited by the phosphatidylinositol 3-kinase inhibitor wortmannin. IL-22 increased the mRNA expression of suppressor of cytokine signaling (SOCS)-3 and the proinflammatory cytokines IL-6, IL-8, and TNF-{alpha}. SOCS-1/3 overexpression abrogated IL-22-induced STAT activation and decreased IL-22-mediated liver cell regeneration. Hepatic IL-22 mRNA expression was detectable in different forms of human hepatitis, and hepatic IL-22 mRNA levels were increased in murine T cell-mediated hepatitis in vivo following cytomegalovirus infection, whereas no significant differences were seen in an in vivo model of ischemia-reperfusion injury. In conclusion, IL-22 promotes liver cell regeneration by increasing hepatic cell proliferation and hepatocyte migration through the activation of Akt and STAT signaling, which is abrogated by SOCS-1/3 overexpression.

interleukin-10-like cytokines; liver regeneration; cell migration; suppressor of cytokine signaling



Address for reprint requests and other correspondence: S. Brand, Dept. of Medicine II, Univ.-Hospital Munich-Grosshadern and Univ. of Munich, Marchioninistrasse 15, 81377 Munich, Germany (e-mail: stephan.brand{at}med.uni-muenchen.de)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.